Table 4.
Anti-migraine drugs |
Results |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug | Reference | Species | Type | SD induction | Dosage | Number | Amplitude | Propagation | Threshold | Duration | Frequency |
Tonabersat | Read et al.192 | Cat | In vivo | KCl | 3–10 mg/kg/day ip. | ↓ | ↑ | ↓ | |||
Tonabersat | Smith et al.193 | Cat | In vivo | KCl | 3–10 mg/kg/day ip. | ↓ | |||||
Tonabersat | Bradley et al.194 | Cat | In vivo | KCl | 10 mg/kg/day ip. | ↓ | ↑ | ↓ | |||
Tonabersat | Read et al.192 | Rat | In vivo | KCl | 10 mg/kg/day ip. | ↓ | |||||
Topiramate | Akerman and Goadsby195 | Cat, rat | In vivo | Mechanical | 30 mg/kg/day iv. | ↓ | = | ||||
Topiramate | Unekawa et al.196 | Rat | In vivo | KCl | 50, 100, 200, or 600 mg/kg ip. | ↓ | ↑ | ||||
Topiramate | Ayata et al.50 | Rat | In vivo | Electrical, KCl | 40–80 mg/kg/day | ↓ | = | ↓ | ↑ | = | |
Topiramate | Tozzi et al.197 | Rat | In vitro | K+ | 100 μM | ↓ | |||||
Flunarizine | Marrannes et al.97 | Rat | In vivo | Electrical | 20–40 mg/kg/day ip.; per os 3 × 20 mg/kg/day | = | = | = | ↓ | ||
Flunarizine | Marrannes et al.97 | Rat | In vivo | Electrical, KCl | 10–20 mg/kg/day ip.; per os 20 mg/kg/day | ||||||
Flunarizine | Hansen and Lauritzen37 | Rat | In vivo | Mechanical | Per os 20 mg/kg/day | = | = | ||||
Flunarizine | Wauquier et al.198 | Rat | In vivo | Mechanical | 40 mg/kg/day ip. | ↓ | |||||
Flunarizine | Li et al.199 | Rat | In vivo | KCl | 3 mg/kg ip. | ↓ | ↓ | ↑ | ↓ | ||
Flunarizine | Ashton et al.200 | Guinea pig | In vitro | Electrical | 40 mg/kg × 2 per os | ↓ | |||||
Valproate | Kaube and Goadsby179 | Cat | In vivo | Mechanical | 3.5–7 mg/kg/day iv. | = | = | = | |||
Valproate | Peeters et al.102 | Rat | In vivo | KCl | 200 mg/kg ip. | = | = | ||||
Valproate | Tepe et al.201 | Rat | In vivo | KCl | 75 mg/kg ip. | = | = | ||||
Valproate | Bogdanov et al.185 | Rat | In vivo | KCl | 200 mg/kg/day ip. | ↓ | ↓ | ||||
Valproate | Hoffmann et al.202 | Rat | In vivo | Electrical, KCl | 200 mg/kg/day ip./iv. | ↑ | |||||
Valproate | Ayata et al.50 | Rat | In vivo | Electrical, KCl | 25/50/100/200 mg/kg/day ip. | ↓ | = | ↓ | ↑ | = | |
Sumatriptan | Bradley et al.194 | Cat | In vivo | KCl | 0.3 mg/kg iv. | = | ↑ | = | |||
Sumatriptan | Read et al.192 | Rat | In vivo | KCl | 0.3 mg/kg iv. | = | |||||
Sumatriptan | Moskowitz et al.203 | Rat | In vivo | KCl | 0.3 mg/kg iv. | = | |||||
Sumatriptan | Srienc et al.110 | Rat retina | In vitro | Photothrombosis | 3 mg/kg iv. | ↓ | = | ↓ | |||
Sumatriptan | Knapp et al.204 | Rat | In vivo | KCl | 0.6 mg/kg ip. | ↓ | |||||
Sumatriptan | Wiedemann et al.205 | Chicken | In vitro | KCl | 1.5 mM | ↓ | ↓ | ↓ | |||
Dihydroergotamine | Kaube and Goadsby179 | Cat | In vivo | Mechanical | 15 mg/kg iv. | = | = | ||||
Ergotamine | Wiedemann et al.205 | Chicken | In vivo | KCl | 10–20 µM | = | = | ||||
Lamotrigine | Bogdanov et al.185 | Rat | In vivo | KCl | 15 mg/kg/day ip. | ↓ | = | ||||
Riboflavin | Bogdanov et al.185 | Rat | In vivo | KCl | 20 mg/kg/day ip. | ↓ | = | ||||
Propranolol | Ayata et al.50 | Rat | In vivo | Electrical, KCl | 20 mg/kg/day ip. | = | = | = | = | = | |
Propranolol | Ayata et al.50 | Rat | In vivo | Electrical, KCl | 20 mg/kg/day ip. | ↓ | = | ↓ | = | = | |
Propranolol | Richter et al.206 | Rat | In vivo | Mechanical | Topical application of 250 – l µmol/L to 1 mmol/L | = | = | ↓ | = | ||
Propranolol | Peeters et al.102 | Adult rat | In vivo | KCl | Ip injection of 20 mg/kg ip. | = | |||||
Propranolol | Wiedemann et al.205 | Chicken | In vitro | KCl | 500 µmol | ↓ | ↓ | ↓ | |||
Methylsergide | Ayata et al.50 | Rat | In vivo | Electrical, KCl | Ip injection of 0.1 and 1 mg/kg/day ip. | ↓ | = | = | = | = | |
Methylsergide | Wiedemann et al.205 | Chicken | In vitro | KCl | 100 µmol | ↓ | ↓ | ↓ | |||
Amitryptolin | Ayata et al.50 | Rat | In vivo | Electrical, KCl | Ip injection of 10/20 mg/kg/day ip. | ↓ | = | = | = | = | |
Clonidin | Wiedemann et al.205 | Chicken | In vitro | KCl | 100–500 µM | = | = | = | |||
Lisuride | Wiedemann et al.205 | Chicken | In vitro | KCl | 100–200 nM | = | = | = | |||
Iprazochrome | Wiedemann et al.205 | Chicken | In vitro | KCl | 100–200 µM | = | = | = | |||
Isoprenalin | Kaube et al.207 | Cat | In vivo | Transection | Topical application of 0.1/1% | = | = | ||||
Amylnitrite | Kaube et al.207 | Cat | In vivo | Transection | Topical application of 0.05% | = | = |
“↓” Means a reductive effect was observed after drug administration, “=” means no effect was noticed, and “↑” means that the tested parameter was increased by drug. Typical parameters under investigation are number, amplitude, propagation, threshold, duration, and frequency. Most substances exert an inhibitory effect on the number of SDs. Only few inhibit more than one variable, for instance, flunarizine, sumatriptan, and propranolol. Experimental settings and models are heterogeneous, comprising different animals (chicken, rat, and cat) and various forms of SD induction (KCl and electrical stimulation).